RCTRF yields 3868.47% · PFE yields 6.13%● Live data
📍 RCTRF pulled ahead of the other in Year 1
Combined, RCTRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RCTRF + PFE for your $10,000?
Trans Canada Gold Corp. operates as an oil and gas exploration, and mining resource development company. It identifies, acquires, and finances the acquisition, exploration, development of mining, and oil and gas assets primarily in Canada, the United States, and Mexico. The company explores for gold, silver, copper, nickel, cobalt, and other deposits. It holds interests in the Gold Crow gold project that covers an area of approximately 15,185 hectares located in Pickle Lake, Ontario; the Dinorwic gold property that consists of 714 non-surveyed contiguous mining claims covering an area of approximately 14,880 hectares located in the northwest of Dryden, Ontario; and C-12 well located in Landrose, Saskatchewan. The company was formerly known as Arctic Hunter Energy Inc. and changed its name to Trans Canada Gold Corp. in January 2021. Trans Canada Gold Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Full RCTRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.